RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY January 2024 slide deck - over 120 panc pts studied I don't mind repeating the answers to reasonable questions.
regarding Onc doing a phase 3 on their own?
It always ( since incorporation & original mission statement), to get Pela to a stage of approval, then partner &/ or be sold.
Partnering has always been their public discussion. Up to & including present day on- line corporate update.
ONC has $$$ funding to operate 12+ months. Ridding Andrew G wages & sanDiego office certainly will help marginally with operational costs.
They do not have $$$ to fund a phase 3 trial,
meaning
1. accelerated approval
2. a pharma license parter deal
3. complete buyout
4. A significant share/ warrent bought deal
5. some other business arrangement, providing funding.
The PanCan arrangement was to solve most of the phase 3 trial timing & costs, but not all.
going by Onc publicized updates etc:
We know phase 3 for panc will happen. It looks to be co- Theapy with Roche.
beyond that?
Stay tuned.